- Title:
- HCV viral decline at week 2 of Peg-IFN-alpha-2a/RBV therapy as a predictive tool for tailoring treatment in HIV/HCV genotype 1 co-infected patients.
- Authors:
- Source:
- PloS one [PLoS One] 2014 Jun 19; Vol. 9 (6), pp. e99468. Date of Electronic Publication: 2014 Jun 19 (Print Publication: 2014).
- Publication Type:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Coinfection/*drug therapy
HIV Infections/*drug therapy
Hepatitis C/*drug therapy
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosageRibavirin /*administration & dosage
Adult ; Antiviral Agents/administration & dosage ; Coinfection/virology ; Female ; Genotype ; HIV Infections/pathology ; HIV Infections/virology ; Hepacivirus/drug effects ; Hepatitis C/pathology ; Hepatitis C/virology ; Humans ; Male ; Middle Aged ; Recombinant Proteins/administration & dosage ; Treatment Outcome ; Viral Load
Academic Journal